PS
IDXX icon

Principal Securities’s Idexx Laboratories IDXX Stock Holding History

Principal Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
2,276
-229
-9% -$128K 0.01% 723
2026
Q1 		$1.41M Sell
2,505
-36
-1% -$23.1K 0.02% 614
2025
Q4 		$1.72M Buy
2,541
+345
+16% +$235K 0.03% 527
2025
Q3 		$1.4M Buy
2,196
+118
+6% +$71.6K 0.02% 551
2025
Q2 		$1.11M Buy
2,078
+1,387
+201% +$663K 0.02% 583
2025
Q1 		$286K Hold
691
– – 0.01% 998
2024
Q4 		$286K Sell
691
-345
-33% -$151K 0.01% 995
2024
Q3 		$523K Sell
1,036
-734
-41% -$357K 0.01% 745
2024
Q2 		$862K Buy
1,770
+30
+2% +$15.1K 0.02% 514
2024
Q1 		$939K Buy
1,740
+163
+10% +$89.1K 0.03% 473
2023
Q4 		$875K Buy
+1,577
New +$740K 0.03% 451

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Principal Securities's IDXX Position: Q2 2026 in Review

Principal Securities reduced its Idexx Laboratories (IDXX) stake by 9.1% in Q2 2026, selling an estimated $128K and leaving 2,276 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #723.

Principal Securities first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.72M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Principal Securities held 2,276 shares of Idexx Laboratories worth $1.2M as of Q2 2026.
  • Principal Securities sold 229 Idexx Laboratories shares in Q2 2026, an estimated $128K.
  • Idexx Laboratories made up 0.01% of Principal Securities's portfolio in Q2 2026, its #723 holding.
  • Principal Securities first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's Idexx Laboratories position peaked at $1.72M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.